MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,150,225 | $27,122,306 | 17.94% |
| COMMODORE CAPITAL LP | 4,428,072 | $104,413,938 | 12.20% |
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $37,728,000 | 12.04% |
| Aquilo Capital Management, LLC | 430,109 | $10,141,970 | 9.19% |
| Ally Bridge Group (NY) LLC | 221,384 | $5,220,235 | 6.13% |
| Fairmount Funds Management LLC | 1,881,345 | $44,362,115 | 5.34% |
| VR Adviser, LLC | 1,726,214 | $40,704,126 | 4.28% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $11,790,000 | 3.58% |
| DAFNA Capital Management LLC | 484,870 | $11,433,235 | 3.56% |
| Nan Fung Group Holdings Ltd | 137,038 | $3,231,356 | 2.62% |
| Boxer Capital, LLC | 1,900,000 | $44,802,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,876,938 | $91,418,198 | 2.01% |
| BVF INC/IL | 2,752,420 | $64,902,064 | 1.75% |
| HighVista Strategies LLC | 122,631 | $2,891,639 | 1.34% |
| SAMLYN CAPITAL, LLC | 3,256,518 | $76,788,694 | 1.26% |
| Frazier Life Sciences Management, L.P. | 746,479 | $17,601,975 | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 253,333 | $5,973,592 | 1.09% |
| TCG Crossover Management, LLC | 300,000 | $7,074,000 | 1.04% |
| RTW INVESTMENTS, LP | 1,996,764 | $47,083,695 | 0.99% |
| Soleus Capital Management, L.P. | 384,490 | $9,066,274 | 0.84% |
External links
This page lists MERUS N V's shareholders in Q3 2023. To view MERUS N V's shareholder history, click here.